Viz.ai and Avicenna.AI recently announced that Viz.ai is integrating Avicenna.AI’s Cina-iPE and Cina-ASPECTS tools ...

Drug Delivery From ATK to BTK: What Is on the Horizon? With moderator Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed(ClinEpi), and panelists Marianne Brodmann, MD; Osamu ...

Merit Medical Systems, Inc. announced that the Wrapsody cell-impermeable endoprosthesis has received premarket approval from t ...

Humacyte, Inc. announced that the FDA has granted full approval for the company’s Symvess—acellular tissue enginee ...

Patient Presentation A male in his early 70s with a history of diabetes mellitus, hypertension, hyperlipidemia, and COVID-19 ...

Patient Presentation A man in his late 50s presented to the emergency department with 4 weeks of acute-onset, severely ...

Biotronik announced the enrollment of the first patients in its BIO-OSCAR FIRST trial, which is designed to confirm the ...

Contego Medical announced the first commercial procedures were performed with the company’s Neuroguard IEP system. Ac ...

Dr. Silver moderates a panel of experts who discuss their experiences with the Neuroguard IEP® System, insights into the data, device design characteristics, and impact on the field.

Two case examples help demonstrate the varied use of PTAB with the DETOUR System in treating superficial femoral artery disease. Percutaneous transmural arterial bypass (PTAB) with the DETOUR™ System ...

Why is venous stent occlusion problematic, and how is it similar to or different from arterial stent occlusion? Dr. O’Sullivan: Veins are obviously fundamentally different from arteries, and venous ...

Penumbra’s commitment to advancing the treatment landscape for venous disease is unmatched. With their Computer Assisted Vacuum Thrombectomy (CAVT™) and embolization platforms, Penumbra’s technology ...